Search Results - "Schmidt, Ryder M"
-
1
Assessment of CT to CBCT contour mapping for radiomic feature analysis in prostate cancer
Published in Scientific reports (23-11-2021)“…This study provides a quantitative assessment of the accuracy of a commercially available deformable image registration (DIR) algorithm to automatically…”
Get full text
Journal Article -
2
Quantifying Radiosensitization of PSMA-Targeted Gold Nanoparticles on Prostate Cancer Cells at Megavoltage Radiation Energies by Monte Carlo Simulation and Local Effect Model
Published in Pharmaceutics (01-10-2022)“…Active targeting gold nanoparticles (AuNPs) are a very promising avenue for cancer treatment with many publications on AuNP mediated radiosensitization at…”
Get full text
Journal Article -
3
In vivo active-targeting fluorescence molecular imaging with adaptive background fluorescence subtraction
Published in Frontiers in oncology (14-03-2023)“…Using active tumor-targeting nanoparticles, fluorescence imaging can provide highly sensitive and specific tumor detection, and precisely guide radiation in…”
Get full text
Journal Article -
4
Assessment of daily dose accumulation for robustly optimized intensity modulated proton therapy treatment of prostate cancer
Published in Physica medica (01-01-2021)“…•Daily CBCTs were used for creation of the synthetic CTs for dose accumulation.•RO-IMPT±3mm/±3% plans are superior to RO-IMPT±5mm/±3% for prostate IMPT…”
Get full text
Journal Article -
5
Boosted Radiation Bystander Effect of PSMA-Targeted Gold Nanoparticles in Prostate Cancer Radiosensitization
Published in Nanomaterials (Basel, Switzerland) (01-12-2022)“…Metal nanoparticles are effective radiosensitizers that locally enhance radiation doses in targeted cancer cells. Compared with other metal nanoparticles, gold…”
Get full text
Journal Article -
6
CBCT-Based Adaptive Assessment Workflow for Intensity Modulated Proton Therapy for Head and Neck Cancer
Published in International journal of particle therapy (01-03-2021)“…Anatomical changes and patient setup uncertainties during intensity modulated proton therapy (IMPT) of head and neck (HN) cancers demand frequent evaluation of…”
Get full text
Journal Article